Delivery Order SPE2DB24D2101-SPE2DB25FKPXZ
- Not listed
- The Defense Logistics Agency awarded a $28,323.36 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Gamunex-C 20 gram/200 mL vials. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs,...
- The Defense Logistics Agency awarded a $6,073.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (5 gram/50 mL vial), a pharmaceutical product for federal medical supply needs. This non-competitive delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Gamunex-C 10 gram/100 mL vials totaling $7,325.64 with a completion date of October 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $33,528.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gamunex-C 10 gram/100 mL vials. The contract is scheduled for completion by October 17, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Gamunex-C 40 gram/400 milliliter vials with a ceiling value of $6,981.60 and an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Gamunex-C 1 gram/10 milliliter vials with a ceiling value of $1,223.80 and a completion date of September 3, 2025. This non-set-aside, firm fixed-price delivery order represents a competitively awarded contract under the company's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion through December...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPXZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,162.44 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Gamunex-C 20 gram/200 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 16, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a child delivery order under a larger contract vehicle. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent contract serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/24/25 |